Comparison of basophil histamine releasability between atopic and nonatopic asthmatics

Journal of Korean Medical Science

Volumn 14, Issue 2, 1999, Pages 153-158

  Son, Jee Woong ^a,b   Kim, Yoon Keun ^b   Chung, Jae Won ^a,b   Lee, Sang Rok ^a,b   Cho, Sang Heon ^a,b   Min, Kyung Up ^a,b   Koh, Young Yull ^a   Kim, You Young ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Asthma; Basophils; Histamine Release; Hypersensitivity, immediate

Indexed keywords

CALCIMYCIN; IMMUNOGLOBULIN E; IONOPHORE;

ARTICLE; ASTHMA; BASOPHIL; BLOOD; CHILD; COMPARATIVE STUDY; DRUG EFFECT; HISTAMINE RELEASE; HUMAN; IMMUNOLOGY;

ASTHMA; BASOPHILS; CALCIMYCIN; CHILD; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; IONOPHORES;

EID: 0033113419     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1999.14.2.153     Document Type: Review

References (28)

1. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with senim IgE levels and skin-test reactivity to allergens. N Engl J Med 1989; 320: 271-7.
2. Lichtenstein LM, Conroy MC. 'The releasbility' of mediators from human basophils and granulocytes. Proceedings of the IX International Congresss of Allergology, Buenos Aires, 1976: 109.
3. Conroy MC, Adkinson NF Jr., Lichtenstein LM. Measurement of IgE on human basophils: Relation to serum IgE and anti-IgE-induced histamine release. J Immunol 1977; 118: 1317-21.
4. Arock M, Merle-Beral H, Dugas B, Ouaaz F, Goff LL, Vouldoukis I, Mencia-Huerta JM, Schmitt C, Leblond-Missenard V, Debre P, Mossalayi MD. IL-4 release by human leukemic and activated normal basophils. J Immunol 1993; 151: 1441-7.
5. MacGlashan D Jr, White JM, Huang SK, Ono SJ, Schroeder JT, LM Lichtenstein. Secretion of IL-4 from human basophils. J Immunol 1994; 152: 3006-15.
6. Schroeder JT, MacGlashan D Jr, Kagey-Sobotka A, White JM, Lichtenstein LM. IgE-dependent IL-4 secretion by human basophils. The relationship between cytokine production and histamine release in mixed leukocyte cultures. J Immunol 1994; 153: 1808-17.
7. 2O. J Immunol 1986; 128: 2067-72.
8. Marone G, Giugliano R, Lembo G, Ayala F. Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis. J Invest Dermatol 1986; 187: 19-23.
9. Casolaro V, Spadaro G, Marone G. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma. Am Rev Repir Dis 1990; 142: 1108-11.
10. Kern F, Lichtenstein LM. Defective histamine release in chronic urticaria. J Clin Invest 1976; 57: 1369-77.
11. Findlay SR, Lichtenstein LM. Basophil 'releasbility' in patients with asthma. Am Rev Respir Dis 1980; 122: 53-9.
12. Gaddy JN, Busse WW. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma. Am Rev Respir Dis 1986; 134: 969-74.
13. Choi BH, Min KU, Kim YY. Allergen mediated histamine release from basophil of bronchial asthmatics. Korean Soc Allergol 1988; 8(3): 215-24.
14. Ferris BG. Epidemiology standardization project II. Recommended respiratory disease questionnaires for use with adults and children in epidemiological research. Am Rev Respir Dis 1978; 118: 10-35.
15. Chai H, Farr RS, Froehlich LA, Mathison DA, McLean JA, Rosenthal RR, Sheffer AL, Spector SL, Townley RG. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56: 534-9.
16. Marone G. The role of mast cell and basophil activation in human allergic reactions. Eur Respir J 1989; 6: 446s-55s.
17. Lichtenstein LM, Bochner BS. The role of basophils in asthma. Ann NY Acad Sci 1991; 629: 48-61.
18. Malveaux FJ, Conroy MC, Adkinson NF Jr, Lichtenstein LM. IgE receptors on human basophils: Relationship to serum IgE concentration. J Clin Invest 1978; 62: 176-81.
19. MacGlashan DW Jr, Lichtenstein LM. Studies of antigen binding on human basophil. I. Antigen binding and functional consequences. J Immunol 1983; 130: 2330-6.
20. Mita H, Yasueda H, Ishii T, Akiyama K. IgE-mediated basophil releasability is influenced by intrinsic factors and by IgE on the cell surface. Allergy 1995; 50: 952-8.
21. MacGlashan DW Jr. Releasability of human basophils: Cellular sensitivity and maximal histamine release are independent variables. J Allergy Clin Immunol 1993; 191: 605-15.
22. Marone G, Poto S, di Martino L, Condorelli M. Human basophil releasability. I. Age-related changes in basophil releasability. J Allergy Clin Immunol. 1986; 77: 377-83.
23. Marone G, Poto S, Celestino D, Bonini S. Control mechanisms of human basophil releasability. J Allergy Clin Immunol 1986; 78: 974-80.
24. Hirai K, Morita Y, Misaki Y, Ohta K, Takaishi T, Suzuki S, Motoyoshi K, Miyamoto T. Modulation of human basophil histamine release by hemopoietic growth factors. J Immunol 1988; 147: 3958-64.
25. Kurimoto Y, DeWeck AL, Dahinden CA. Interleukin 3-dependent mediator release in basophils triggered by C5a. J Exp Med 1989; 170: 467-79.
26. Hirai K, Yamaguchi M, Misaki Y, Takaishi T, Ohta K, Morita Y, Ito K, Miyamoto T. Enhancement of human basophil histamine release by interleukin 5. J Exp Med 1990; 172: 1525-8.
27. Bischoff SC, Brunner T, Weck AL, Dahinden CA. Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med 1990; 172: 1577-82.
28. Schroeder JT, Kagey-Sobotka A, MacGlashan DW, Lichtenstein LM. The interaction of cytokines with human basophils and mast cells. Int Arch Allergy Immunol 1995; 107: 79-81.